|
Market Closed -
Other stock markets
|
After market 03:59:43 pm | |||
| 12.28 EUR | +6.23% |
|
12.3 | +0.16% |
| Apr. 17 | Medincell: share price rises following agreement with AbbVie | CF |
| Apr. 16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
MedinCell S.A. reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was EUR 4.09 million compared to EUR 8.19 million a year ago. Revenue was EUR 8.34 million compared to EUR 11.78 million a year ago.
Net loss was EUR 24.81 million compared to EUR 18.99 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +70.56% | 354M | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B |
MEDINCELL S.A. 
